Error: Could not add to watchlist. X

Mirati Therapeutics Inc

+ Watchlist
MYLGF:US
Ticker Delisted
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Mirati Therapeutics, Inc. is a targeted oncology company developing a pipeline of therapeutics for precisely defined patient populations. The Mirati team is using a blueprint proven by their prior work for developing potential breakthrough therapies with accelerated development paths.
ADDRESS
9363 Towne Centre Drive
Suite 200
San Diego, CA 92121
United States
PHONE
858-535-2075
  • Charles M Baum
    President/CEO
  • Mark J Gergen
    Exec VP/COO
  • Isan Chen
    Exec VP/Chief Medical & Dev Ofcr
  • James Christensen
    Senior VP/Chief Scientfic Ofcr
  • Jamie A Donadio
    VP:Finance
Show More